Menu
  • Video
  • Audio
  • Images
  • Collections
  • About
Sign in
ASRS A project from the American Soceity of Retina Specialists
Share feedback      Sign in
ASRS Multimedia Library
ASRS A project from the American Society of Retina Specialists
Search by condition, keyword, or author name
  • Video
  • Audio
  • Images
  • Collections
  • About
  1. Collections
  2. Updates from the Field

Sign in to view content

Sign in

Brolucizumab for Neovascular AMD: The 2 Year HAWK and HARRIER Results

  • Pravin U. Dugel, MD
  • Video
  • Published 2018

Related

  • Continuous submicrogram fluocinolone acetonide (FAc) therapy for the treatment of diabetic retinopathy

    Charles C Wykoff, MD, PhD, FASRS

    Updates from the Field

    2017

  • Phase 3 Randomized, Double-Masked Studies of Brolucizumab Versus Aflibercept in nAMD: Expanded Primary and Secondary Outcomes From HAWK/HARRIER

    Arshad M. Khanani, MD, MA, FASRS

    Annual Meeting Talks

    2018

  • Real World Experience of Brolucizumab for Persistent Macular Fluid in Neovascular Age-Related Macular Degeneration After Prior Anti-VEGF Treatments

    Rehan M. Hussain, MD

    Annual Meeting Talks

    2021

Category: AMD-Neovascular

  • Pharmacology
  • brolucizumab
  • Neovascualar AMD Clinical Trials

See more

  • Updates from the Field
  • Pravin U. Dugel, MD
  • ASRS Multimedia Library
  • Video
  • Audio
  • Images
  • Collections
American Society of Retina Specialists20 North Wacker Drive, Suite 2030,Chicago, Illinois 60606(312) 578-8760 phoneinfo@asrs.org
© 2025 The American Society of Retina Specialists. All rights reserved. Privacy statement. Terms of use.